Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Aug;51(2):98-102.
doi: 10.1016/j.jinf.2004.09.008.

The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study

Tung Wai Auyeung  1 , Jenny S W Lee, Wing Kin Lai, Chun Hung Choi, Hoi Kan Lee, Joo Shim Lee, Po Chun Li, Ka Ho Lok, Yuk Yung Ng, Wai Ming Wong, Yiu Ming Yeung
Affiliations

The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study

Tung Wai Auyeung et al. J Infect. 2005 Aug.

Abstract

Objective: To study the effect of corticosteroids in the treatment of severe acute respiratory syndrome (SARS).

Methods: A retrospective cohort of 78 consecutive adult SARS patients admitted to a regional hospital in Hong Kong between March and May 2003 was analysed to study the effectiveness of corticosteroid. They were categorized according to whether or not corticosteroid therapy was given, and compared in terms of demographic characteristics, comorbidities, peak lactate dehydrogenase (LDH) levels and clinical outcomes. Established adverse prognostic factors including old age, comorbidities and high LDH levels were used as covariates in multiple logistic regressions to adjust for their confounding effect on adverse outcomes.

Results: Among 78 patients, 66 patients (84.6%) received corticosteroid. The LDH level was similar in both groups. The corticosteroid group had more adverse outcomes (37.9% vs. 16.7%) despite younger age and less comorbidity. In multivariate analysis, corticosteroid treatment was associated with a 20.7-fold increase in risk of either ICU admission or mortality, independent of age and disease severity.

Conclusion: Despite more favourable baseline characteristics and similar peak LDH levels, SARS patients given corticosteroid had more adverse outcomes.

PubMed Disclaimer

Comment in

References

    1. Lee N., Hui D., Wu A. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003;348:1986–1994. - PubMed
    1. Wong G.W.K., Hui D.S.C. Severe acute respiratory syndrome (SARS): epidemiology, diagnosis and management. Thorax. 2003;58:558–560. - PMC - PubMed
    1. Tsui P.T., Kwok M.L., Yuen H., Lai S.T. Severe acute respiratory syndrome: clinical outcome and prognostic correlates. Emerg Infect Dis. 2003;9:1064–1069. - PMC - PubMed
    1. Peiris J.S.M., Lai S.T., Poon L.L.M. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet. 2003;361:1319–1325. - PMC - PubMed
    1. So L.K., Lau A.C., Yam L.Y. Development of a standard treatment protocol for severe acute respiratory syndrome. Lancet. 2003;361:1615–1617. - PMC - PubMed

MeSH terms